LGR5 and cancer: Recent advances in the field have focused on novel biomarkers for cancer stem cell identification, such as Lgr5 (a G-protein-coupled receptor), that could eventually be targeted in an attempt to reverse this innate resistance of tumors to chemotherapy and RT [30].